经口机器人手术时代的囗咽癌三联治疗:是否存在可能获益的队列
回顾性研究分析囗咽癌接受三联治疗的患者,比较双侧与单侧颈部放疗的结局和毒性。436例接受经口机器人手术,17%接受辅助放化疗,院内完成辅助治疗的46例中20%豁免对侧颈部。单侧颈部放疗者生存无显著差异,唾液功能、情绪和焦虑的患者报告结局更优,且与局部结构平均剂量直接相关。
要点
- 囗咽癌经口机器人手术后三联治疗中,单侧颈部放疗的生存与双侧放疗无显著差异。
- 单侧颈部放疗者唾液功能、情绪和焦虑的患者报告结局优于双侧放疗者。
- 患者报告结局与局部结构平均剂量直接相关。
核心结论
- 囗咽癌手术可通过豁免对侧颈部来减少放疗体积,即使接受同步化疗,单侧颈部放疗毒性谱良好且不损害生存。
研究设计与样本
- 回顾性研究,纳入在三级医院接受三联治疗的囗咽癌患者,比较双侧与单侧颈部放疗。
- 436例患者接受经口机器人手术,其中17%接受辅助放化疗。
- 46例在院内完成辅助治疗,其中20%豁免对侧颈部。
主要发现
- 生存方面无显著差异。
- 单侧颈部放疗患者的唾液功能、情绪和焦虑患者报告结局优于双侧颈部放疗患者。
- 患者报告结局与局部结构平均剂量直接相关。
临床怎么用
- 作者认为,囗咽癌手术为可能需根治性放化疗的患者提供了减少放疗体积、豁免对侧颈部的可能。
- 作者认为,即使接受同步化疗,单侧颈部放疗毒性谱良好且不损害生存。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With increasing adoption of transoral robotic surgery (TORS) for oropharyngeal cancer (OPC), more patients may receive trimodality therapy. We sought to investigate outcomes and toxicities in this cohort. METHODS: A retrospective study of patients with OPC treated with trimodality therapy at a tertiary-care hospital, comparing those receiving bilateral vs unilateral neck radiation. RESULTS: Four hundred thirty-six patients underwent TORS, 17% receiving adjuvant chemoradiation. Of the 46 patients completing adjuvant treatment in-house, contralateral neck was spared in 20%. There were no significant differences in survival, and patient-reported outcomes in salivary function, mood, and anxiety were superior in those patients receiving unilateral neck radiation and directly correlated with mean dose to local structures. CONCLUSIONS: Surgery for OPC offers the potential for reduction in radiation volumes by omitting the contralateral neck in those who may have required definitive chemoradiation. Even in patients receiving concurrent chemotherapy, unilateral neck radiation has a favorable toxicity profile without compromising survival.
引用
- Gallitto M, Sindhu K, Wasserman I, et al. Trimodality therapy for oropharyngeal cancer in the TORS era: Is there a cohort that may benefit? Head Neck. 2019. PMID: 30997703. doi:10.1002/hed.25779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。